Edwin Alvarez - Concepedia

Author

Edwin Alvarez

University of California San Diego ORCID

Also Known As

E A Alvarez, E Alvarez, E. A. Alvarez, E. Alvarez, E.A. Alvarez, Edwin A. Alvarez, Edwin A Alvarez, Edwin A. Alvarez, Edwin Alexander Alvarez, Edwin Alvarez

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego University of California, San Francisco Moores Cancer Center Sylvester Comprehensive Cancer Center University of Miami

About

Edwin Alvarez is an author at University of California San Diego specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	549
2	Health Sciences	2	2	25
3	Cell Biology	2	2	68
4	Nursing	1	1	11
5	Public Health	1	1	60

Edwin Alvarez

Publications

953

Citations

H-Index

Page 1

	Year	Citations
Cardiovascular disease is the leading cause of death among endometrial cancer patients Kristy Ward, Nina R. Shah, Cheryl Saenz, Gynecologic Oncology Cancer RiskEndocrine-related CancerCardiovascular DiseaseMedicineGynecology	2012	253
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study Edwin Alvarez, William E. Brady, Joan L. Walker, Gynecologic Oncology Phase Ii TrialMedicineCancer ManagementMetronomic TherapyGynecology	2012	143
Tight Junction Proteins Claudin-3 and Claudin-4 Control Tumor Growth and Metastases Xiying Shang, Xinjian Lin, Edwin Alvarez, Neoplasia	2012	101
<i>NTRK</i> fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma Joseph T. Rabban, W. Patrick Devine, Ankur R. Sangoi, Histopathology	2020	91
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis Kazuki N. Sugahara, Pablo Scodeller, Gary B. Braun, Journal of Controlled Release Tumor-penetrating PeptideDrug TargetingPeptide TherapeuticTumor TargetingRadiation Oncology	2015	71
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial Ana Oaknin, Claire F. Friedman, Lynda D. Roman, Gynecologic Oncology	2020	70
Changing demographics of cervical cancer in the United States (1973–2008) Kristy Ward, Nina R. Shah, Cheryl Saenz, Gynecologic Oncology Cervical Cancer ScreeningCervical Cancer ManagementPrecancerous LesionsCervical HealthCancer Epidemiology	2012	60
Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo Yi Chen, Edwin Alvarez, Diana J. Azzam, Breast Cancer Research and Treatment Breast OncologyMedicineCancer BiologyBreast CancerAnti-cancer Agent	2010	53
Smoking Decreases Survival in Locally Advanced Cervical Cancer Treated With Radiation Jyoti Mayadev, Jihoon Lim, Blythe Durbin‐Johnson, American Journal of Clinical Oncology	2016	33
Alcohol Abuse Decreases Pelvic Control and Survival in Cervical Cancer Jyoti Mayadev, Chin‐Shang Li, Jihoon Lim, American Journal of Clinical Oncology	2015	19

Page 1